Cardiff Oncology (CRDF) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

CRDF is expected to report earnings to -24 cents per share on February 27

Cardiff Oncology CRDF Stock Earnings Reports

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.02

Q2'24

Missed

by $0.01

Q1'24

Beat

by $0.03

Q4'23

Beat

by $0.06

The last earnings report on November 07 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 290.90K shares outstanding, the current market capitalization sits at 127.83M.

View a ticker or compare two or three

Compare

CRDF

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRDF
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a cancer medicine oncology therapeutics company, which engages in the development of drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, lymphomas, and solid tumors

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

11055 Flintkote Avenue

Phone

+1 858 952-7570

Employees

Web

https://www.cardiffoncology.com